Table 4. Characteristics of the subsample of the population used for assessment of associations between inflammatory molecules levels from PBMCs extracts and VEGF mRNA isoforms (n = 110).
| Mean | SD | |
|---|---|---|
| Age (years) | 47.35 | 10.78 |
| Gender (%) male | 48.18 | - |
| Interleukin 1 alpha (pg/mL) | 0.81 | 2.75 |
| Interleukin 1 beta (pg/mL) | 4.88 | 17.42 |
| Interleukin 2 (pg/mL) | 0.90 | 1.3 |
| Interleukin 4 (pg/mL) | 7.75 | 1.55 |
| Interleukin 6 (pg/mL) | 0.614 | 1.22 |
| Interleukin 8 (pg/mL) | 67.65 | 135.91 |
| Interleukin 10 (pg/mL) | 0.65 | 0.24 |
| Interferon gamma (pg/mL) | 0.30 | 0.36 |
| Tumour Necrosis Factor alpha (pg/mL) | 3.85 | 16.55 |
| Monocyte Chemoattractant Protein 1 (pg/mL) | 9.58 | 5.59 |
| Epidermal Growth Factor (pg/mL) | 6.84 | 7.09 |
| VEGF 121 | 47.96 | 19.95 |
| VEGF 145 | 47.19 | 22.52 |
| VEGF 165 | 250.52 | 111.77 |
| VEGF 189 | 15.03 | 7.17 |
VEGF: Vascular endothelial growth factor, VEGF transcript copies number/25 ng cDNA